Xiamen Kingdomway Stock Hits Day High with Strong Intraday Performance

Xiamen Kingdomway Group Co., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable increase of 3.09% on March 6, 2026. The stock reached an intraday high of CNY 18.71, reflecting a strong performance compared to the China Shanghai Composite, which rose by only 0.38% on the same day. Despite a challenging week with a decline of 4.7%, Xiamen Kingdomway has shown resilience over the past year, boasting a remarkable 31.78% increase in stock value. This performance is underscored by a significant rise in net profit, which grew by 59.97% in the first half of the year, alongside a return on capital employed (ROCE) of 11.26%. The company has also benefited from a decrease in raw material costs, which fell by 4.98% year-over-year. With a market capitalization of CNY 11,374 million, Xiamen Kingdomway maintains a competitive edge in its industry, supported by a solid return on equity of 11.11% and a favorable price-to-book ratio of 2.51. The stock's current dividend yield stands at 2.14%, further enhancing its appeal in the market.